Bedrest may affect cholesterol dynamics differently depending on age
A new study examining cholesteryl esters suggests that periods of prolonged inactivity may affect people differently depending on their age. Cholesteryl esters — which consist of cholesterol molecules bonded with fatty acids — store and transport cholesterol throughout the body.
As people get older, their risk of being hospitalized or bedridden increases. These long periods of inactivity come with a host of negative health effects such as reduced insulin function and loss of lean muscle, bone mass and strength. Scientists are working to better understand the biology involved in these changes so that therapies can be developed that reduce the negative consequences of physical inactivity.

Trevor Romsdahl, a research scientist at the University of Texas Medical Branch in Galveston, led a recent study.
“We measured the cholesteryl esters from blood plasma collected during bed-rest studies focused on middle-aged and older adults,” he said. “To our knowledge no study has measured the specific molecular species of cholesteryl esters during a bedrest study. Most other work has focused on measuring low-density lipoprotein and high-density lipoprotein cholesterol concentrations.”
Romsdahl will present the research at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, which is being held March 23–26 in San Antonio.
Cholesteryl esters are important in key biological processes such as lipid metabolism, cellular function and overall maintenance of health. Dysregulation of cholesteryl ester metabolism can play a role in the development of cardiovascular diseases and metabolic disorders.
“There's very little information on the biological significance of cholesteryl esters with different fatty acids, which differ in terms of chain length and degrees of unsaturation,” Romsdahl said. “Also, much of the research examining cholesterol changes and bed rest has been done in younger adults.”
For the new study, Romsdahl’s team partnered with Emily J. Arentson–Lantz, an assistant professor at the University of Texas Medical Branch, to analyze plasma samples she acquired in bed-rest studies that were focused on middle-aged and older adults. To measure specific molecular species of cholesteryl esters, the team developed a sensitive analysis method based on liquid chromatography and tandem mass spectrometry. It involved using a highly hydrophobic C30 liquid chromatography column to separate different cholesteryl ester species based on what fatty acid they contained.
The analysis showed that during bed rest several cholesteryl esters tended to increase in middle-aged subjects but decrease in older adults. However, the researchers observed similar changes in middle-aged and older adults when post-recovery levels were compared with pre–bed-rest levels.
“More research is needed to better understand the biological significance of these results and what effect they may have on health,” Romsdahl said. “However, it is possible that altering or supplementing meals with certain fatty acids versus others could subtly shift the cholesteryl ester species to a healthier profile.”
Trevor Romsdahl will present this research during a poster session from 4:30 to 6:30 p.m. CDT on Sunday, March 24, in the exhibit hall of the Henry B. González Convention Center (Poster Board No. 335) (abstract).
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Teaching AI to listen
A computational medicine graduate student reflects on building natural language processing tools that extract meaning from messy clinical notes — transforming how we identify genetic risk while redefining what it means to listen in science.

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder
Lipid profiling in a rare disease mouse model reveals metabolic shifts and inflammation in the retinal pigment epithelium — offering promising biomarker leads to combat blindness.

How sugars shape Marfan syndrome
Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.